Vijayakumar Velu

Cytowane przez

	Wszystkie	Od 2020
Cytowania	5208	2093
h-indeks	40	23
i10-indeks	75	54

500

250

125

375

200720082009201020112012201320142015201620172018201920202021202220232024202524 63 93 135 180 243 271 253 287 343 360 409 397 412 481 424 368 352 52

Dostęp publiczny

Wyświetl wszystko

85 artykułów

1 artykuł

dostępne

niedostępne

Objęte finansowaniem

Współautorzy

Rama AmaraCharles Howard Candler Professor of Microbiology and Immunology, Emory UniversityZweryfikowany adres z emory.edu
Prof. E. M. Shankar, PhD, FRCPathInfection and Inflammation, Department of Biotechnology, Central University of Tamil NaduZweryfikowany adres z cutn.ac.in
Marie Larsson, LiUProfessor, Linköping UniversityZweryfikowany adres z liu.se
Yean Kong YongXiamen University MalaysiaZweryfikowany adres z xmu.edu.my
Vignesh Ramachandran, PhDRoyal College of Medicine Perak, Universiti Kuala Lumpur (UniKL RCMP)Zweryfikowany adres z unikl.edu.my
Gordon FreemanDana-Farber Cancer Institute, Harvard Medical SchoolUnknown affiliationZweryfikowany adres z dfci.harvard.edu
Dr. Pachamuthu BalakrishnanProfessor & Chief Scientist - Infectious Diseases, MAHER (Deemed to be University), ChennaiZweryfikowany adres z maher.ac.in
Rafi AhmedDirector of Emory Vaccine CenterZweryfikowany adres z emory.edu
Dr. S. P. ThyagarajanSri Ramachandra Institute of Higher Education and ResearchZweryfikowany adres z sriramachandra.edu.in
Kehmia TitanjiEmory University School of MedicineZweryfikowany adres z emory.edu
Kamarulzaman AdeebaMonash University MalaysiaZweryfikowany adres z monash.edu
Sakthivel GovindarajEmory UniversityZweryfikowany adres z emory.edu
Steven BosingerEmory UniversityZweryfikowany adres z emory.edu
Kumarasamy N or Nagalingeswaran KVHS Infectious Diseases Medical CentreZweryfikowany adres z cartcrs.org
guido silvestriemory universityZweryfikowany adres z emory.edu
Sunil Kannanganat SidharthanResearch Associate, Baylor College of MedicineZweryfikowany adres z bcm.edu
Pradeep ReddyAssociate Scientific Director, moderna, Cambridge, MAZweryfikowany adres z emory.edu
David C Montefiori, Ph.D.Duke University Medical CenterZweryfikowany adres z duke.edu
Suraj B. SableStaff Scientist, Immunology, Centers for Disease Control and PreventionZweryfikowany adres z cdc.gov
Kumarasamy ThangarajCentre for Cellular and Molecular BiologyZweryfikowany adres z ccmb.res.in

Obserwuj

Vijayakumar Velu

Emory Vaccine Center, Emory University.

Zweryfikowany adres z emory.edu - Strona główna

HIV Vaccine Development Immunotherapy Therapeutic Vaccines.


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Enhancing SIV-specific immunity in vivo by PD-1 blockade V Velu, K Titanji, B Zhu, S Husain, A Pladevega, L Lai, TH Vanderford, ... Nature 458 (7235), 206-210, 2009	985	2009
PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques RD Shetty, V Velu, K Titanji, SE Bosinger, GJ Freeman, G Silvestri, ... The Journal of clinical investigation 122 (5), 1712-1716, 2012	196	2012
Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India S Saravanan, V Velu, S Nandakumar, SP Thyagarajan, N Kumarasamy, ... World J Gastroenterol 13 (37), 5015-5020, 2007	176	2007
Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination V Velu, S Kannanganat, C Ibegbu, L Chennareddi, F Villinger, ... Journal of virology 81 (11), 5819-5828, 2007	168	2007
Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options V Velu, RD Shetty, M Larsson, EM Shankar Retrovirology 12, 1-17, 2015	164	2015
Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques K Titanji, V Velu, L Chennareddi, M Vijay-Kumar, AT Gewirtz, GJ Freeman, ... The Journal of clinical investigation 120 (11), 3878-3890, 2010	144	2010
Molecular signatures of T-cell inhibition in HIV-1 infection M Larsson, EM Shankar, KF Che, A Saeidi, R Ellegård, M Barathan, ... Retrovirology 10, 1-14, 2013	142	2013
Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection GH Mylvaganam, D Rios, HM Abdelaal, S Iyer, G Tharp, M Mavigner, ... Proceedings of the National Academy of Sciences 114 (8), 1976-1981, 2017	135	2017
HIV–Mycobacterium tuberculosis co-infection: a ‘danger-couple model’ of disease pathogenesis EM Shankar, R Vignesh, R Ellegård, M Barathan, YK Chong, MK Bador, ... Pathogens and disease 70 (2), 110-118, 2014	122	2014
Induction of Th1-biased T follicular helper (Tfh) cells in lymphoid tissues during chronic simian immunodeficiency virus infection defines functionally distinct germinal center … V Velu, GH Mylvaganam, S Gangadhara, JJ Hong, SS Iyer, S Gumber, ... The Journal of Immunology 197 (5), 1832-1842, 2016	107	2016
Attrition of TCR Vα7. 2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression A Saeidi, VL Tien Tien, R Al-Batran, HA Al-Darraji, HY Tan, YK Yong, ... PLoS One 10 (4), e0124659, 2015	101	2015
Immune biomarkers for diagnosis and treatment monitoring of tuberculosis: current developments and future prospects YK Yong, HY Tan, A Saeidi, WF Wong, R Vignesh, V Velu, R Eri, ... Frontiers in microbiology 10, 2789, 2019	98	2019
Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161⁺⁺TCR iVα7.2⁺ Mucosal-Associated … YK Yong, A Saeidi, HY Tan, M Rosmawati, PF Enström, RA Batran, ... Frontiers in immunology 9, 472, 2018	98	2018
Loss of IL-17–producing CD8 T Cells during late chronic stage of pathogenic simian immunodeficiency virus infection P Nigam, S Kwa, V Velu, RR Amara The Journal of Immunology 186 (2), 745-753, 2011	97	2011
Peripheral loss of CD8⁺CD161⁺⁺TCRVα7·2⁺ mucosal‐associated invariant T cells in chronic hepatitis C virus‐infected patients M Barathan, R Mohamed, J Vadivelu, LY Chang, A Saeidi, YK Yong, ... European journal of clinical investigation 46 (2), 170-180, 2016	95	2016
Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine GA Kardar, M Jeddi‐Tehrani, F Shokri Scandinavian journal of immunology 55 (3), 311-314, 2002	93	2002
Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished … P Nigam, V Velu, S Kannanganat, L Chennareddi, S Kwa, M Siddiqui, ... The journal of immunology 184 (4), 1690-1701, 2010	92	2010
Combination anti–PD-1 and antiretroviral therapy provides therapeutic benefit against SIV GH Mylvaganam, LS Chea, GK Tharp, S Hicks, V Velu, SS Iyer, ... JCI insight 3 (18), e122940, 2018	86	2018
Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. S Saravanan, V Velu, S Nandakumar, V Madhavan, ... Journal of microbiology, immunology, and infection= Wei mian yu gan ran za …, 2009	81	2009
Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin FB Sow, S Nandakumar, V Velu, KL Kellar, LS Schlesinger, RR Amara, ... Tuberculosis 91 (4), 314-321, 2011	79	2011

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy